SheMed Built a $1 Billion Business on GLP-1s. Its Next Bet Goes Beyond Weight Loss

The Quick Take
SheMed’s study of more than 8,000 women found improvements in weight, blood sugar, and cholesterol. Its founders believe that’s just the start of what GLP-1 research could uncover.
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to Inc.com.



